Jong-hyuk Sung
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Venlafaxine reverses chemotherapy-induced alopecia through epithelial and dermal reprogramming at single-cell resolution.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 16, 2026
Special Issue "Molecular Insights into Hair Regeneration".
Journal: International journal of molecular sciences
Published: December 16, 2025
Insights into the context-dependent immunological roles of the CXCL12-CXCR4 axis in alopecia.
Journal: Frontiers in immunology
Published: November 25, 2025
CXCL12 Drives Reversible Fibroimmune Remodeling in Androgenetic Alopecia Revealed by Single-Cell RNA Sequencing.
Journal: International journal of molecular sciences
Published: June 17, 2025
Recent Advances in Drug Development for Hair Loss.
Journal: International journal of molecular sciences
Published: March 07, 2025
Off‑the‑shelf, engineered non-living stem cell strategy for advancing cellular therapies.
Journal: Nature biomedical engineering
Published: February 16, 2025
The Involvement of RIPK1 in Alopecia Areata.
Journal: International journal of molecular sciences
Published: January 08, 2025
Differential Expression of CXCL12 in Human and Mouse Hair: Androgens Induce CXCL12 in Human Dermal Papilla and Dermal Sheath Cup.
Journal: International journal of molecular sciences
Published: November 29, 2024
Differential expression of androgen receptor and 5-α reductase isoforms in skin cells.
Journal: Archives of dermatological research
Published: September 24, 2024
Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing.
Journal: Frontiers in immunology
Published: June 06, 2024
Recent approaches of antibody therapeutics in androgenetic alopecia.
Journal: Frontiers in pharmacology
Published: May 19, 2024
Last Updated: 09/26/2026